OPTIAID
Natural health product licensed in Canada
- Other names
- ENIGMA OPTIAID
- Licence holder
- CANADIAN NEUTRICEUTICAL HEALTH INC.
- NPN or DIN-HM
- 80096399
- Status
- Active licence
- Licence date
- 31 December 2019
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Dose déclarée au-delà d'une limite
Chrome: up to 35 µg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Zinc Source : Citrate de zinc | 7.5 mg | 7,500 µg |
| Vitamine A Source : Acétate de vitamine A | 5,000 UI | Not calculated |
| Vitamine A Source : Acétate de vitamine A | 1,494 mg RAE | Not calculated |
| (3R,3'R)-bêta,bêta-Carotène-3,3'-diol Source : Zeaxanthin | 2 mg | Not calculated |
| Vitamine E Source : Succinate d'acide de dl-alpha tocophéryle | 12.5 mg AT | Not calculated |
| Chrome Source : Nicotinate de chrome (III) | 35 mcg | 35 µg |
| Vitamine E Source : Succinate d'acide de dl-alpha tocophéryle | 27.78 UI | Not calculated |
| Vitamine C Source : Acide ascorbique | 150 mg | 150,000 µg |
Non-medicinal ingredients
Phosphate de dicalcium dihydraté, Dioxyde de silicium, Cellulose microcristalline, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Helps to improve macular pigment optical density. Helps to maintain eyesight/support eye health in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Source of/Provides antioxidants for the maintenance of eye health. Helps to maintain eyesight/skin/membranes/(and) immune function (health). Helps to maintain eyesight and in the development and maintenance of night vision. Source of/An antioxidant for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you have a history of non-melanoma skin cancer.
Source
Official Health Canada record, licence 80096399
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.